Monday, February 25, 2019

Novartis in-licenses Akcea's novel cardiovascular therapy - PMLiVE https://t.co/t2S8RMcJon


from Twitter https://twitter.com/IDROOhio

February 25, 2019 at 03:13AM
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)